Biochemical blood indicators in patients with diabetes mellitus type I and II

Abstract

Diabetes mellitus (DM) is a consequence of a disruption in the insulin regulation functions of a range of cells in the body. The regulation disruption can be associated with a decrease in insulin production or damage to the insulin signal transduction mechanisms. According to the World Health Organization experts’ assessment, the number of individuals with diabetes worldwide is increasing and has already become a significant medical and social issue for the populations of many countries [2]. This is characterized by the development of micro- and macrovascular complications, leading to the occurrence of heart attacks and strokes. According to the Ministry of Health (MOH) data, Ukraine has approximately 1,3 million individuals with diabetes, with the vast majority, more than 90,0%, being patients with type II diabetes.